功能障碍对严重心力衰竭患者预后的影响:一项回顾性队列研究
Jia Li1, Yiming Chu, Minmin Huang
1Department of Critical Care Medicine, Haimen District People's Hospital, Nantong, Jiangsu, China.
Medicine
|October 15, 2025
概括
在严重心力衰竭 (HF) 患者中,功能衰竭很常见,影响存活率. 在晚期HF中早期发现和治疗功能障碍对于改善患者的治疗结果和减少住院治疗至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 严重的心力衰竭 (HF),特别是纽约心脏协会 (NYHA) 的第四级心力衰竭,带来了复杂的临床挑战.
- 功能衰竭是已知的HF共患病,但其在晚期的特定影响需要进一步调查.
- 鉴定功能障碍的预测因子对于风险分层和针对性干预对HF患者至关重要.
研究的目的:
- 为了确定NYHA类IV心力衰竭患者功能缺陷的患病率.
- 评估不同程度的功能衰竭对死亡率和再住院率的预后影响.
- 在这个患者群体中确定与功能障碍相关的独立临床预测因素.
主要方法:
- 在120名患有NYHA IV类HF的患者进行了回顾性队列研究.
- 患者分为正常功能 (eGFR ≥90),轻度 (60 ≤ eGFR <90) 和中度至重度 (eGFR <60) 的功能不足.
- 分析包括多变量回归和Kaplan-Meier人口统计,生化和生存数据的生存分析.
主要成果:
- 66.67%的患者患有功能衰竭;31.67%的患者患有中度至重度的功能衰竭.
- 功能障碍的独立预测因素包括年龄,血清肌素,血液尿素和triiodothyronine水平.
- 中度至重度的功能衰竭与显著更高的全因死亡率 (47.37%) 和再住院率 (60.53%) 相关.
结论:
- 中度至重度的功能衰竭在晚期心力衰竭患者中非常普遍.
- 功能障碍显著恶化了临床结果,包括生存率和再住院率.
- 早期检测和量身定制的管理策略对于改善这种高风险HF人群的结果至关重要.
相关概念视频
01:22Heart Failure Drugs: Diuretics
804
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
804
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
932
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
932
01:11Renal Failure: Dose Adjustments
437
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
437
01:17Factors Affecting Renal Clearance: Renal Impairment
425
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
425
01:22Heart Failure VI: Adjunct Therapies
255
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
255
01:17Pathophysiology of Heart Failure
2.9K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.9K